5AM Venture Management’s Cidara Therapeutics CDTX Stock Holding History

5AM Venture Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-56,725	Closed	-$1.22M	–	31
2025 Q1	$1.22M	Hold	56,725	–	–	0.46%	29
2024 Q4	$1.52M	Hold	56,725	–	–	0.36%	30
2024 Q3	$610K	Hold	56,725	–	–	0.13%	28
2024 Q2	$677K	Sell	56,725 -1	-0%	-$14	0.15%	27
2024 Q1	$1.04M	Hold	56,726	–	–	0.23%	26
2023 Q4	$901K	Hold	56,726	–	–	0.24%	25
2023 Q3	$1.07M	Hold	56,726	–	–	0.31%	26
2023 Q2	$1.28M	Hold	56,726	–	–	0.32%	24
2023 Q1	$1.44M	Hold	56,726	–	–	0.37%	23
2022 Q4	$858K	Hold	56,726	–	–	0.23%	21
2022 Q3	$712K	Hold	56,726	–	–	0.14%	21
2022 Q2	$554K	Hold	56,726	–	–	0.14%	21
2022 Q1	$945K	Hold	56,726	–	–	0.21%	19
2021 Q4	$1.44M	Hold	56,726	–	–	0.27%	17
2021 Q3	$2.54M	Sell	56,726 -43,600	-43%	-$1.66M	0.52%	15
2021 Q2	$4.05M	Hold	100,326	–	–	1.02%	11
2021 Q1	$5.34M	Hold	100,326	–	–	0.96%	9
2020 Q4	$4.01M	Hold	100,326	–	–	1.35%	9
2020 Q3	$5.72M	Hold	100,326	–	–	1.5%	9
2020 Q2	$7.4M	Hold	100,326	–	–	1.62%	9
2020 Q1	$4.98M	Hold	100,326	–	–	1.54%	8
2019 Q4	$7.71M	Buy	+100,326	New	+$4.59M	1.66%	8

Other funds holding CDTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

5AM Venture Management's CDTX Position: Q2 2025 in Review

5AM Venture Management sold out of Cidara Therapeutics (CDTX) in Q2 2025, closing a stake of 56,725 shares — an estimated $1.22M sold.

5AM Venture Management first reported a position in CDTX in Q4 2019 and held it in 22 quarters. The position peaked at $7.71M in Q4 2019. 109 funds tracked by Wall St. Rank hold CDTX as of Q2 2025.

5AM Venture Management reported no remaining Cidara Therapeutics position as of Q2 2025 after selling out during the quarter.
5AM Venture Management sold 56,725 Cidara Therapeutics shares in Q2 2025, an estimated $1.22M.
5AM Venture Management first reported a position in Cidara Therapeutics in Q4 2019 and held it in 22 quarters.
5AM Venture Management's Cidara Therapeutics position peaked at $7.71M in Q4 2019.
109 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2025.

Based on 5AM Venture Management's 13F filing for Q2 2025, filed 14 Aug 2025.